Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone intervention study in heart failure
MOH_2021-07-13_010126Phase 2Not yet recruiting
- Sponsor
- פרופ' עופר אמיר
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of glatiramer acetate in heart failure (HF) (2 arms), sponsored by פרופ' עופר אמיר. Primary endpoint: Primary endpoint not reported. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
glatiramer acetate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on MOH_2021-07-13_010126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-07-13_010126.